New research shows the common joint supplement glucosamine may accelerate Alzheimer's progression. People with mild cognitive impairment taking it were 25% more likely to develop dementia, and diagnosed Alzheimer's patients faced a 25% higher death risk.
New research from the University of Florida indicates that glucosamine, a widely used supplement for joint pain, may accelerate the progression of Alzheimer's disease. The study found a significant as
